FOCALIN

This brand name is authorized in Estonia, United States

Active ingredients

The drug FOCALIN contains one active pharmaceutical ingredient (API):

1 Dexmethylphenidate UNII 1678OK0E08 - DEXMETHYLPHENIDATE HYDROCHLORIDE

Dexmethylphenidate is a CNS stimulant. It is the more pharmacologically active d-enantiomer of racemic methylphenidate. Methylphenidate blocks the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space. The mode of therapeutic action in Attention Deficit Hyperactivity Disorder (ADHD) is not known. Read about Dexmethylphenidate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FOCALIN Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06BA11		N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BA Centrally acting sympathomimetics
Discover more medicines within N06BA11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1748987
Country: US	FDA, National Drug Code	Identifier(s): 0078-0380, 0078-0381, 0078-0382, 0078-0430, 0078-0431, 0078-0432, 0078-0433, 0078-0434, 0078-0493, 0078-0608, 0078-0609